Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04662879 · ClinicalTrials.gov registry record · NA
Early Detection Initiative for Pancreatic Cancer
A NA study of Diabetes Mellitus and Hyperglycemia, sponsored by Pancreatic Cancer Action Network.
- Active
- Registry status
- NA
- Development phase
- 8,869
- Enrollment target
- 2
- Study locations
NCT04662879 is a NA study of Diabetes Mellitus and Hyperglycemia that is active but no longer recruiting, run by Pancreatic Cancer Action Network. The registered enrollment target is 8,869 participants, above the 1,825-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (386% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT04662879, a NA study of Diabetes Mellitus and Hyperglycemia, is active but no longer recruiting, sponsored by Pancreatic Cancer Action Network.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 8,869 participants
- Enrollment target
- 2
- Study locations
Study Summary
The Early Detection Initiative for Pancreatic Cancer is a multi-center prospective study to determine if algorithm-based screening in patients with glycemically defined new onset hyperglycemia and diabetes has the potential for earlier detection of pancreatic ductal adenocarcinoma.
Conditions Studied
Interventions
- OTHER Enriching New-onset Diabetes for Pancreatic Cancer (ENDPAC) score
- OTHER Abdominal imaging
Study Locations (2)
California
- Kaiser Permanente Southern California, Kaiser Permanente Research - Pasadena
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,869 participants |
| Start Date | 2021-10-14 |
| Est. Completion | 2028-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04662879
The ClinicalTrials.gov registry entry for NCT04662879 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 8,869 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,825-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (386% higher). The listed sponsor is Pancreatic Cancer Action Network, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Enriching New-onset Diabetes for Pancreatic Cancer (ENDPAC) score is the first listed.
NCT04662879 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Texas.
Frequently Asked Questions
What is clinical trial NCT04662879 about?
NCT04662879 is a clinical study titled "Early Detection Initiative for Pancreatic Cancer". The Early Detection Initiative for Pancreatic Cancer is a multi-center prospective study to determine if algorithm-based screening in patients with glycemically defined new onset hyperglycemia and diabetes has the potential for earlier detection of pancreatic ductal adenocarcinoma.
What is the current status of trial NCT04662879?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 8,869 participants. The study started on 2021-10-14. Estimated completion is 2028-01.
What conditions does trial NCT04662879 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Hyperglycemia, Pancreas Ductal Adenocarcinoma.
What interventions are being tested in trial NCT04662879?
The interventions under investigation include: Enriching New-onset Diabetes for Pancreatic Cancer (ENDPAC) score (OTHER), Abdominal imaging (OTHER).
Who is sponsoring clinical trial NCT04662879?
This trial is sponsored by Pancreatic Cancer Action Network, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04662879 being conducted?
This trial has 2 study locations across California, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.